Ethical and policy issues relating to progenitor-cell-based strategies for prevention of atherosclerosis

, &
Journal of Medical Ethics 33 (11):643-646 (2007)
  Copy   BIBTEX

Abstract

Experiments have suggested that umbilical cord blood stem cells can be used to prevent diseases such as atherosclerosis. This paper discusses ethical issues surrounding such usage such as the uncertainty that individuals at risk of a disease will actually get the disease; issues related to research with children; safety issues; from where these stem cells would be obtained; and whether these usages should be considered as therapies or as physical enhancements.

Categories

Keywords

Reprint years

DOI

10.1136/jme.2006.017251

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,349

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Safety Issues In Cell-Based Intervention Trials.Liza Dawson, Alison S. Bateman-House, Dawn Mueller Agnew, Hilary Bok, Dan W. Brock, Aravinda Chakravarti, Mark Greene, Patricia King, Stephen J. O'Brien, David H. Sachs, Kathryn E. Schill, Andrew Siegel & Davor Solter - 2003 - Fertility and Sterility 80 (5):1077-1085.
Heart disease and social inequality: Ethical issues in the aetiology, prevention and treatment of heart disease.Paula Boddington - 2009 - Bioethics 23 (2):123-130.
Equity, utility, and the marketplace: Emerging ethical issues of umbilical cord blood banking in australia. [REVIEW]Gabrielle N. Samuel & Ian H. Kerridge - 2007 - Journal of Bioethical Inquiry 4 (1):57-63.
Broadening the scope of debates around stem cell research.Tamra Lysaght & Alastair V. Campbell - 2012 - Bioethics 27 (5):251-256.
Stem cell research: An ethical evaluation of policy options.Nikolaus Knoepffler - 2004 - Kennedy Institute of Ethics Journal 14 (1):55-74.
Will Embryonic Stem Cells Change Health Policy?William M. Sage - 2010 - Journal of Law, Medicine and Ethics 38 (2):342-351.
Hematopoietic Stem Cell Transplantation: Legal and Ethical Issues in the UK.David Shaw - forthcoming - In Jörg P. Halter Peter Bürkli (ed.), The Legal and Ethical Challenges of Present and Future Stem-Cell Transplantation. Schwabe Verlag.
Uncertain translation, uncertain benefit and uncertain risk: Ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.Ronald K. F. Fung & Ian H. Kerridge - 2011 - Bioethics 27 (2):89-96.
The gap between law and ethics in human embryonic stem cell research: Overcoming the effect of U.s. Federal policy on research advances and public benefit.Patrick L. Taylor - 2005 - Science and Engineering Ethics 11 (4):589-616.
Stem Cell Research as Innovation: Expanding the Ethical and Policy Conversation.Rebecca Dresser - 2010 - Journal of Law, Medicine and Ethics 38 (2):332-341.
The Commercialization of Human Stem Cells: Ethical and Policy Issues. [REVIEW]David B. Resnik - 2002 - Health Care Analysis 10 (2):127-154.
Ethical issues in human embryonic stem cell research.Philip J. Nickel - 2008 - In Kristen Renwick Monroe, Ronald B. Miller & Jerome Tobis (eds.), Fundamentals of the Stem Cell Debate: The Scientific, Religious, Ethical & Political Issues. University of California Press.
Allowing Innovative Stem Cell-Based Therapies Outside of Clinical Trials: Ethical and Policy Challenges.Insoo Hyun - 2010 - Journal of Law, Medicine and Ethics 38 (2):277-285.
Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease.Bernard Lo & Lindsay Parham - 2010 - Journal of Law, Medicine and Ethics 38 (2):257-266.

Analytics

Added to PP
2010-08-24

Downloads
32 (#487,332)

6 months
18 (#135,061)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

S. Matthew Liao
New York University
Paul Goldschmidt
Yeshiva University

Citations of this work

Add more citations

References found in this work

No references found.

Add more references